It is predicted that artificial intelligence (AI) will transform many aspects of our life including healthcare and genomics. AI and machine learning have helped us to understand the genome of organisms and will potentially change the way we treat disease, determine effective drugs and edit genes.
Category: bioengineering – Page 160
LEXINGTON, Ky. (NOVEMBER 15, 2018) – Space Tango, a leader in the commercialization of space through R&D, bioengineering and manufacturing in microgravity, today announced ST-42, a fully autonomous robotic orbital platform designed specifically for scalable manufacturing in space. Launching in the mid 2020’s, ST-42 aims to harness the unique environment of microgravity to produce high value products across industries; from patient therapeutics to advanced technology products that have the potential to revolutionize industries here on Earth. ST-42 is an extension of the International Space Station’s (ISS) capabilities, and NASA’s creation of a robust commercial marketplace in low Earth orbit (LEO).
ST-42 will bring the economics of production in orbit into reality coupling autonomy with the reduced cost and larger number of launch vehicle providers. Space Tango expects the platform to be at the forefront of new breakthroughs in knowledge discovery, therapeutic solutions and manufacturing, and to provide the required capabilities for creation of new biomedical and technology product sectors in the commercial Space economy.
Rutgers scientists have created a tiny, biodegradable scaffold to transplant stem cells and deliver drugs, which may help treat Alzheimer’s and Parkinson’s diseases, aging brain degeneration, spinal cord injuries and traumatic brain injuries.
Stem cell transplantation, which shows promise as a treatment for central nervous system diseases, has been hampered by low cell survival rates, incomplete differentiation of cells and limited growth of neural connections.
So, Rutgers scientists designed bio-scaffolds that mimic natural tissue and got good results in test tubes and mice, according to a study in Nature Communications. These nano-size scaffolds hold promise for advanced stem cell transplantation and neural tissue engineering. Stem cell therapy leads to stem cells becoming neurons and can restore neural circuits.
In the spirit of Halloween, where ghouls, ghosts, and vampires walk among us, our perception of reality will soon transform as well, forever possessed by the specter of Transhumanism!
Last year, I wrote about how people could transform themselves into one of my favorite horror creatures—a real-life werewolf—using modern science and tech. This merely scratches the surface, however, in terms of how far an individual can go. In a Transhumanist future, you’ll be empowered to not only question the extent of your humanity but equally put those questions into action.
The route one would be able to take would be in abundance. Some will choose a cybernetic route, replacing their organs and limbs for artificial machines, and even potentially adding newer organs and limbs alongside the ones they already have. Others may choose a more biological route by using gene-editing tech and synthetic biology, enhancing themselves at the genetic level and using stem cell therapies to maintain their bodily health for prolong periods of time.
http://www.aztecauno.com/vengalaalegria) — The importance of an integrated approach to curing spinal cord injury including family, physical therapists, and the medical team at Regenerage (https://regenerage.clinic/)
Wonderful to see the continuing progress of Mr. Omar Flores, with the support of his lovely wife, actress Mayra Sierra, today on the Venga la Alegria (VLA) show on TV Azteca (Biohacking raises a host of ethical issues, particularly about data protection and cybersecurity as virtually every tech gadget risks being hacked or manipulated. And implants can even become cyberweapons, with the potential to send malicious links to others. “You can switch off and put away an infected smartphone, but you can’t do that with an implant,” says Friedemann Ebelt, an activist with Digitalcourage, a German data privacy and internet rights group.
Patrick Kramer sticks a needle into a customer’s hand and injects a microchip the size of a grain of rice under the skin. “You’re now a cyborg,” he says after plastering a Band-Aid on the small wound between Guilherme Geronimo’s thumb and index finger. The 34-year-old Brazilian plans to use the chip, similar to those implanted in millions of cats, dogs, and livestock, to unlock doors and store a digital business card.
Kramer is chief executive officer of Digiwell, a Hamburg startup in what aficionados call body hacking—digital technology inserted into people. Kramer says he’s implanted about 2,000 such chips in the past 18 months, and he has three in his own hands: to open his office door, store medical data, and share his contact information. Digiwell is one of a handful of companies offering similar services, and biohacking advocates estimate there are about 100,000 cyborgs worldwide. “The question isn’t ‘Do you have a microchip?’ ” Kramer says. “It’s more like, ‘How many?’ We’ve entered the mainstream.”
Research house Gartner Inc. identified do-it-yourself biohacking as one of five technology trends—others include artificial intelligence and blockchain—with the potential to disrupt businesses. The human augmentation market, which includes implants as well as bionic limbs and fledgling computer-brain connections, will grow more than tenfold, to $2.3 billion, by 2025, as industries as diverse as health care, defense, sports, and manufacturing adopt such technologies, researcher OG Analysis predicts. “We’re only at the beginning of this trend,” says Oliver Bendel, a professor at the University of Applied Sciences & Arts Northwestern Switzerland who specializes in machine ethics.